Enfermería
Departamento
Gregory Y.H.
Lip
Publicaciones en las que colabora con Gregory Y.H. Lip (72)
2024
-
Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures
Nature Reviews Cardiology
-
Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients
Revista Espanola de Cardiologia, Vol. 77, Núm. 10, pp. 835-842
-
Impact of prior oral anticoagulation therapies on post-discharge outcomes after COVID-19: Results from a global federated health network analysis
European Journal of Clinical Investigation
2023
-
Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis
Journal of Clinical Medicine, Vol. 12, Núm. 8
-
Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis
Clinical Cardiology, Vol. 46, Núm. 6, pp. 656-662
-
Epilepsy-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications in patients with Epilepsy
Current Problems in Cardiology, Vol. 48, Núm. 10
-
Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis
European Journal of Internal Medicine
-
Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making
American Heart Journal, Vol. 258, pp. 1-16
-
Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review
Science of the Total Environment, Vol. 880
-
Incident heart failure, arrhythmias and cardiovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database
Diabetes, Obesity and Metabolism, Vol. 25, Núm. 2, pp. 602-610
-
Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea
FASEB Journal, Vol. 37, Núm. 6
-
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Biomedicine and Pharmacotherapy, Vol. 158
-
Response to letter from Du et al. regarding article ‘Sodium-glucose cotransporter-2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?’
Diabetes, Obesity and Metabolism
-
Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia
Heart and Lung, Vol. 59, pp. 61-66
-
The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
Journal of General Internal Medicine, Vol. 38, Núm. 2, pp. 315-323
-
Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis
Internal and Emergency Medicine, Vol. 18, Núm. 2, pp. 423-428
2022
-
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry
Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465
-
Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients
Thrombosis and Haemostasis, Vol. 122, Núm. 3, pp. 406-414
-
Anthropometric Measures and Risk of Cardiovascular Disease: Is there an Opportunity for Non-Traditional Anthropometric Assessment? A Review
Reviews in Cardiovascular Medicine, Vol. 23, Núm. 12
-
Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry
Europace, Vol. 24, Núm. 2, pp. 202-210